Nanobodies as innovative immune checkpoint modulators: advancing cancer immunotherapy.

Saved in:
Bibliographic Details
Title: Nanobodies as innovative immune checkpoint modulators: advancing cancer immunotherapy.
Authors: Hosseininejad-Chafi M; Venom and Biotherapeutics Molecules Laboratory, Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, 1316943551, Iran., Eftekhari Z; Venom and Biotherapeutics Molecules Laboratory, Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, 1316943551, Iran., Oghalaie A; Venom and Biotherapeutics Molecules Laboratory, Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, 1316943551, Iran., Behdani M; Venom and Biotherapeutics Molecules Laboratory, Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, 1316943551, Iran., Sotoudeh N; Venom and Biotherapeutics Molecules Laboratory, Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, 1316943551, Iran., Kazemi-Lomedasht F; Venom and Biotherapeutics Molecules Laboratory, Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, 1316943551, Iran. fatemeh1044@yahoo.com.
Source: Medical oncology (Northwood, London, England) [Med Oncol] 2024 Dec 24; Vol. 42 (1), pp. 36. Date of Electronic Publication: 2024 Dec 24.
Publication Type: Journal Article; Review
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-131X (Electronic) Linking ISSN: 13570560 NLM ISO Abbreviation: Med Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1559-131X
DOI:10.1007/s12032-024-02588-y